Teva Pharmaceutical Industries (TEVA) Non-Current Assets (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Non-Current Assets of $26.1 billion in Q2 2026, down 5.1% from $27.51 billion a year earlier and down 0.9% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Teva Pharmaceutical Industries reported Non-Current Assets of $26.8 billion, up 0.1% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $26.77 billion in FY2024 (-13.6%), $30.99 billion in FY2023 (-3.0%), $31.96 billion in FY2022 (-8.9%) and $35.09 billion in FY2021 (-6.8%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q2 2010.
- On a year-over-year basis, Non-Current Assets rose in 1 of the last eight quarters, with an average decline of 6.5%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 0.1% in Q4 2025, against a decline of 13.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $26.33 billion (Q1 2026), $26.8 billion (Q4 2025) and $27.12 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | 26.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.10 Bn |
| Mar 31, 2026 | 26.33 Bn |
| Dec 31, 2025 | 26.80 Bn |
| Sep 30, 2025 | 27.12 Bn |
| Jun 30, 2025 | 27.51 Bn |
| Mar 31, 2025 | 26.89 Bn |
| Dec 31, 2024 | 26.77 Bn |
| Sep 30, 2024 | 29.44 Bn |
| Jun 30, 2024 | 29.71 Bn |
| Mar 31, 2024 | 30.48 Bn |
| Dec 31, 2023 | 30.99 Bn |
| Sep 30, 2023 | 30.67 Bn |
| Jun 30, 2023 | 31.01 Bn |
| Mar 31, 2023 | 31.96 Bn |
| Dec 31, 2022 | 31.96 Bn |
| Sep 30, 2022 | 32.80 Bn |
| Jun 30, 2022 | 33.77 Bn |
| Mar 31, 2022 | 34.61 Bn |
| Dec 31, 2021 | 35.09 Bn |
| Sep 30, 2021 | 35.70 Bn |
API Access
Teva Pharmaceutical Industries Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();